Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus

Southern Medical Journal

Volumn 98, Issue 6, 2005, Pages 590-595

  Wynn, Melissa ^b   Dalovisio, Joseph R ^a   Tice, Alan D ^b   Jiang, Xiaozhang ^b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b NONE

Author keywords

Ceftriaxone; Outpatient parenteral antimicrobial therapy; Skin infections; Staphylococcus aureus; Vancomycin

Indexed keywords

CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; METICILLIN; NAFCILLIN; OXACILLIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL ARTHRITIS; BURSITIS; CATHETER INFECTION; CHRONIC OSTEOMYELITIS; DIARRHEA; DISKITIS; DRUG EFFICACY; DRUG SAFETY; ENDOCARDITIS; FEMALE; FEVER; HUMAN; INJECTION SITE REACTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEPHROTOXICITY; OSTEOMYELITIS; OUTPATIENT; PARENTERAL DRUG ADMINISTRATION; PHLEBITIS; PRESCHOOL CHILD; PROSTHESIS INFECTION; RASH; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THROMBOSIS; VOMITING; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEFAZOLIN; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; DRUG MONITORING; FEMALE; HOME INFUSION THERAPY; HUMANS; INFANT; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; NAFCILLIN; OXACILLIN; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 20544469932     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000145300.28736.BB     Document Type: Article

References (9)

1. Williams DN, Rehm SJ, Tice AD, et al. Practice guidelines for community-based parenteral anti-infective therapy: ISDA Practice Guidelines Committee. Clin Infect Dis 1997;25:787-801.
2. Bernard L, El-hajj, Pron B, et al. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Ther 2001;26:445-451.
3. Deery HG II. Outpatient parenteral anti-infective therapy for skin and soft-tissue infections. Infect Dis Clin North Am 1998;12:935-949.
4. Nathwani D, Tice A. Ambulatory antimicrobial use: the value of an outcomes registry. J Antimicrob Chemother 2002;49:149-154.
5. Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis 2004;38:1651-1672.
6. Tice AD, Schleis TG, Nolet B, et al. Outcomes registry for outpatient IV antimicrobial therapy. Infusion 2000;6:27-35.
7. Parsonnet J, Deresiewicz RL. Staphylococcal infections, in Braunwald E, Fauci AS, Kasper DL, et al (eds): Harrison 's Principles of Internal Medicine. 15th ed. New York: McGraw Hill, 2001, pp 889-901.
8. Martinelli LP, Tice A, Hoaglund P. Outpatient parenteral antimicrobial therapy (OPAT): safety, efficacy and outcomes. Presented at the 38th Annual Meeting of the Infectious Diseases Society of America, New Orleans, LA, September 7 to 10, 2000.
9. Tice A, Seibold G, Martinelli L. Adverse effects from intravenous antibiotics with OPAT. Presented at the 40th Annual Meeting of the Infectious Diseases Society of America, Chicago, L, October 24 to 27, 2002. Poster No. 59.